We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
HCA Healthcare's Top Line Grows on Buyouts, Bad Debts Hurt
Read MoreHide Full Article
HCA Healthcare, Inc. (HCA - Free Report) has been witnessing consistent growth in its revenue base. In the past five years, revenues have recorded a compound annual growth rate of nearly 7% on the back of organic and inorganic strategies. For 2017, it expects revenues to range within $43-$44 billion, reflecting 4% year-over-year growth.
The Nashville, TN-based company has been growing through buyouts over past many years. In 2017, its two major acquisitions of Florida and Texas hospitals from Community Health Systems, Inc (CYH - Free Report) are worth a mention. These deals have boosted patient volumes and expanded network across several markets.
The company’s strong financial position has supported its inorganic initiatives. HCA Healthcare has witnessed impressive cash flow generation over years enabling it to deploy capital in the most effective manner. The company has been paying dividends at regular intervals. It has also been taking up share buyback programs to enhance return to investors.
However, lately, the company’s commercial business has been facing challenges from declining volumes of admissions. Its international business is also under pressure due to a fall in admissions in Middle East and London. High level of bad debt is also a major headwind for the company.
Further, it also suffers from the prevailing industry-wide softness in volumes. Factors such as payor initiatives to move volumes away from hospitals, rising deductibles and prevalence of high deductible health plans, and increased proportion of hospital care to be paid by consumers are driving away volumes.
The company also faces challenges due to the constant uncertainty stemming from President Trump and the Republican Congress’ efforts to repeal and replace Obamacare. The recent tax bill that ends the “individual mandate” (which required most Americans to obtain health insurance or pay a fine) is also expected to result in higher uninsured rate going forward.
Moreover, as continued losses from public exchanges led the health insurers to scale back their participation from exchanges, the uninsured rate continues to increase, hurting the company.
Other players in the industry like Universal Health Services, Inc. (UHS - Free Report) and Tenet Healthcare Corporation. (THC - Free Report) are also victims of this political uncertainty.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Image: Bigstock
HCA Healthcare's Top Line Grows on Buyouts, Bad Debts Hurt
HCA Healthcare, Inc. (HCA - Free Report) has been witnessing consistent growth in its revenue base. In the past five years, revenues have recorded a compound annual growth rate of nearly 7% on the back of organic and inorganic strategies. For 2017, it expects revenues to range within $43-$44 billion, reflecting 4% year-over-year growth.
The Nashville, TN-based company has been growing through buyouts over past many years. In 2017, its two major acquisitions of Florida and Texas hospitals from Community Health Systems, Inc (CYH - Free Report) are worth a mention. These deals have boosted patient volumes and expanded network across several markets.
The company’s strong financial position has supported its inorganic initiatives. HCA Healthcare has witnessed impressive cash flow generation over years enabling it to deploy capital in the most effective manner. The company has been paying dividends at regular intervals. It has also been taking up share buyback programs to enhance return to investors.
However, lately, the company’s commercial business has been facing challenges from declining volumes of admissions. Its international business is also under pressure due to a fall in admissions in Middle East and London. High level of bad debt is also a major headwind for the company.
Further, it also suffers from the prevailing industry-wide softness in volumes. Factors such as payor initiatives to move volumes away from hospitals, rising deductibles and prevalence of high deductible health plans, and increased proportion of hospital care to be paid by consumers are driving away volumes.
The company also faces challenges due to the constant uncertainty stemming from President Trump and the Republican Congress’ efforts to repeal and replace Obamacare. The recent tax bill that ends the “individual mandate” (which required most Americans to obtain health insurance or pay a fine) is also expected to result in higher uninsured rate going forward.
Moreover, as continued losses from public exchanges led the health insurers to scale back their participation from exchanges, the uninsured rate continues to increase, hurting the company.
Other players in the industry like Universal Health Services, Inc. (UHS - Free Report) and Tenet Healthcare Corporation. (THC - Free Report) are also victims of this political uncertainty.
Wall Street’s Next Amazon
Zacks EVP Kevin Matras believes this familiar stock has only just begun its climb to become one of the greatest investments of all time. It’s a once-in-a-generation opportunity to invest in pure genius.
Click for details >>